---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-005537"
form_type: "8-K"
ticker: "BGLC"
cik: "0001737523"
company_name: "BioNexus Gene Lab Corp"
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:16:14.648091+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# BioNexus Gene Lab reduces stockholder meeting quorum to one-third

## Summary
- Board adopted amended bylaws on September 4, 2024, effective immediately.
- Quorum for stockholder meetings lowered from majority to one-third of outstanding voting shares.
- Amendment aligns with other governance provisions; no other bylaw changes disclosed.
- Amended and Restated Bylaws filed as Exhibit 3.1 to the 8-K.

## SEC filing metadata
- accession: 0001477932-24-005537
- form_type: 8-K
- ticker: BGLC
- cik: 0001737523
- company_name: BioNexus Gene Lab Corp
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005537/0001477932-24-005537-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737523/000147793224005537/bglc_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-005537
- JSON: https://secwatch.observer/filing/0001477932-24-005537.json
- Plain text: https://secwatch.observer/filing/0001477932-24-005537.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.